INVOKAMET Trademark

Trademark Overview

On Friday, February 22, 2013, a trademark application was filed for INVOKAMET with the United States Patent and Trademark Office. The USPTO has given the INVOKAMET trademark a serial number of 85857070. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, December 3, 2020. This trademark is owned by JOHNSON & JOHNSON. The INVOKAMET trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceuticals for the prevention or treatment of metabolic diseases
invokamet

General Information

Serial Number85857070
Word MarkINVOKAMET
Filing DateFriday, February 22, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, December 3, 2020
Registration Number4629331
Registration DateTuesday, October 28, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2013

Trademark Statements

Goods and ServicesHuman pharmaceuticals for the prevention or treatment of metabolic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 28, 2013
Primary Code005
First Use Anywhere DateTuesday, August 12, 2014
First Use In Commerce DateTuesday, August 12, 2014

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Saturday, October 28, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 3, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 3, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 1, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 24, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, October 28, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 17, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 28, 2014REGISTERED-PRINCIPAL REGISTER
Saturday, September 20, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 19, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 28, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 14, 2014USE AMENDMENT FILED
Thursday, August 14, 2014TEAS STATEMENT OF USE RECEIVED
Saturday, August 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 8, 2014SOU EXTENSION 2 GRANTED
Tuesday, July 15, 2014SOU EXTENSION 2 FILED
Friday, August 8, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 15, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, January 21, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 17, 2014SOU EXTENSION 1 GRANTED
Friday, January 17, 2014SOU EXTENSION 1 FILED
Friday, January 17, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 17, 2013ASSIGNED TO EXAMINER
Thursday, February 28, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 26, 2013NEW APPLICATION ENTERED

Related Keywords

invokamet metabolic diseases treatment prevention pharmaceuticals human